NEW ORLEANS–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24IMMU&src=ctag" target="_blank"gt;$IMMUlt;/agt; lt;a href="https://twitter.com/hashtag/IMMU?src=hash" target="_blank"gt;#IMMUlt;/agt;–ClaimsFiler, a FREE shareholder information service, reminds investors that they have only until February 25, 2019 to file lead plaintiff applications in a securities class action lawsuit against Immunomedics, Inc. (NasdaqGM: IMMU). Investor losses must relate to purchases of the Company’s shares between the expanded period of February 8, 2018 and January 18, 2019. This action is pending in the United States District Court for the District of New Jersey. Get Help I

Source link